Back to Authors

Seyahi, Emire

Mayo Clinic

Departments of Neurology (B.Z., U.U., S.S., O.N.D., A.S.) and Rheumatology (E.S., S.U., V.H.), Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey; and Department of Neurology (B.Z., O.H.K.), Mayo Clinic College of Medicine, Rochester, MN.

Citations 1

Infliximab is a plausible alternative for neurologic complications of Behçet disease
Zeydan, Burcu , Saip, Sabahattin , Demirci, Onat , Hamuryudan, Vedat , Sıva, Aksel , Kantarci, Orhun H. , Uygunoğlu, Uğur , Demirci, Onat N, Seyahi, Emire, Uğurlu, Serdal , Seyahi, Emire , Siva, Aksel , Zeydan, Burcu

Neurology Neuroimmunology & Neuroinflammation | July 12, 2016 | Volume: 3 | Issue: 5 | Pages: No page available

10.1212/nxi.0000000000000258 Get It